PIK3CD and B-cell chronic lymphocytic leukemia: Inhibition of p110δ PI3K by CAL-101 in cells from patients with CLL led to inhibition of Akt and ERK and consequently to reduced B-CLL survival (Herman et al., 2010; Hoellenriegel et al., 2011).